Pliant Therapeutics Cash Flow Statement (2019-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Operating Activities
Net Income (Quarter)	-27.14M	-23.46M	-29.56M	-30.15M	-33.44M	-35.80M	-41.78M	-48.56M	-47.67M	-62.88M	-53.73M	-61.63M	-61.43M	-55.02M	-59.90M	-86.29M	-29.05M	-15.01M	-57.31M	-22.37M
Depreciation and Depletion (Quarter)	0.40M	0.40M	0.50M	0.40M	0.50M	0.43M	0.45M	0.40M	0.50M	0.44M	0.50M	0.60M	0.50M	0.46M	0.45M	0.40M	0.40M	0.37M	0.30M	0.20M
Share-based Compensation (Quarter)	2.81M	2.77M	3.53M	3.40M	4.81M	-10.79M	11.92M	13.05M	10.36M	9.15M	23.70M	6.10M	-0.57M	8.42M	8.91M	6.38M	6.42M	4.53M	4.25M	4.19M
Cash from Operations (Quarter)	-22.51M	-19.86M	-20.50M	-24.40M	-18.50M	-31.24M	-30.28M	-24.76M	-36.22M	-25.10M	-30.27M	-45.30M	-32.27M	-47.66M	-48.86M	-40.60M	-21.08M	-17.79M	-19.23M	-12.80M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)			-0.27M	-0.17M	0.71M	1.54M	2.58M	3.93M	3.70M		-1.09M	0.15M	-1.00M
Amortization of Deferred Charges (Quarter)	0.42M	0.81M	0.24M	0.44M	0.58M	0.60M	0.61M	0.63M	0.60M	0.56M	0.68M	1.15M	0.81M	0.81M	0.81M	0.81M	0.82M	0.83M	0.83M	0.84M
Depreciation & Amortization (CF) (Quarter)	0.40M	0.40M	0.50M	0.40M	0.50M	0.43M	0.45M	0.40M	0.50M	0.44M	0.50M	0.60M	0.50M	0.46M	0.45M	0.40M	0.40M	0.37M	0.30M	0.20M
Change in Working Capital
Change in Receivables (Quarter)	-0.22M	0.39M	-0.75M	3.74M	-3.51M	0.50M	1.31M	-1.72M	-1.58M
Change in Account Payables (Quarter)	-0.34M	0.49M	1.77M	-1.57M	0.05M	-1.60M	-0.14M	0.88M	1.06M	1.17M	2.26M	-3.63M	3.73M	-0.93M	-0.34M	-4.24M	-0.90M	-0.00M	-0.12M	1.17M
Change in Accured Expenses (Quarter)	2.05M	1.98M	-0.36M	5.77M	2.91M	-0.41M	-0.54M	5.62M	-3.00M	0.70M	-0.91M	5.68M	5.17M	-6.13M	-4.81M	-3.81M	-2.03M	-1.51M	-6.47M	4.42M
Other Working Capital Changes (Quarter)	-0.45M	-0.84M	-0.28M	-0.47M	-0.62M	-0.89M	-0.66M	-0.68M	-0.67M	-0.74M	-0.36M	-0.28M	-0.08M	-0.09M	-0.09M	0.13M	-0.60M	-0.31M	-0.32M	-0.04M
Investing Activities
Capital Expenditures (Quarter)	0.48M	-1.30M	0.64M	0.25M	-0.86M	1.73M		0.77M	0.09M	0.06M		2.74M	-2.61M	3.72M	0.26M	-0.15M	0.26M	-0.42M	-0.32M	0.19M
Sales of Property, Plant and Equipment (Quarter)																		-0.00M	0.10M	0.02M
Change in Acquisitions & Divestments (Quarter)	75.72M	64.30M	41.40M	45.57M	33.80M	56.50M	102.58M	112.10M	152.82M	89.48M	113.41M	60.48M	108.89M	72.70M	83.53M	87.21M	80.33M	86.85M	60.70M	32.79M
Cash from Investing Activities (Quarter)	32.10M	25.78M	1.53M	6.50M	-178.25M	20.02M	-174.21M	-22.98M	38.25M	31.92M	59.55M	10.70M	30.96M	39.13M	69.11M	35.49M	27.92M	1.77M	-4.10M	15.49M
Financing Activities
Other financing activities (Quarter)	-1.74M				216.20M		270.25M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)						-0.15M					19.91M			-19.91M				32.27M
Change in Capital Stock
Shares Issued (Quarter)
Net Equity Issued and Repurchased (Quarter)
Misc.
Cash from Financing Activities (Quarter)	0.45M	0.52M	-0.15M	10.43M	216.30M	0.28M	273.33M	0.16M	0.70M	0.22M	21.79M	0.68M	0.54M	0.10M	0.50M		0.07M	-32.27M	0.07M
Change in Cash (Quarter)	10.04M	6.43M	-19.12M	-7.47M	19.55M	-10.93M	68.84M	-47.58M	2.73M	7.04M	51.06M	-33.91M	-0.77M	-8.43M	20.75M	-5.12M	6.91M	-48.29M	-23.25M	2.69M
Free Cash Flow (Quarter)	-22.99M	-18.56M	-21.14M	-24.65M	-17.63M	-32.97M	-30.28M	-25.52M	-36.32M	-25.16M	-30.27M	-48.04M	-29.66M	-51.38M	-49.13M	-40.45M	-21.34M	-17.37M	-18.91M	-12.99M
Net Cash Flow (Quarter)	10.04M	6.43M	-19.12M	-7.47M	19.55M	-10.93M	68.84M	-47.58M	2.73M	7.04M	51.06M	-33.91M	-0.77M	-8.43M	20.75M	-5.12M	6.91M	-48.29M	-23.25M	2.69M

Research Tools

Datasets

Plans

Developers

Pliant Therapeutics PLRX Cash Flow Statement (2019-2026)

Research Tools

Datasets

Plans

Developers

Pliant Therapeutics PLRX Cash Flow Statement (2019-2026)

Create an account

Sign In

Reset Password